MMP2 and neoplasm: On the other hand, the bioactivity of lovastatin was recently found to reduce the expression of matrix metalloproteinase (MMP)-9 and MMP-2, as well as the suppression of the Ras isoprenylation, which could subsequently decrease the invasive ability of tumor cells [28,29].